Amgen is looking to buy more respiratory assets and be a leader now that GSK is stepping down from respiratory. Amgen to merge with AZ. McKinsey has been hired for dilligence.
New pipeline priority in oncology and new business areas. Respiratory will be a priority if TSLP ends up being a hit and Amgen wants new and better assets in this area.
CLP is wasted program at Amgen. Talent is all smoke and mirrors. They are paying for high GMAT scores and that's it